Editorial: Immune-mediated control of HIV

Katharine J Bar¹, Ole S Søgaard^{2

3}

Affiliations

¹ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Department of Infectious Diseases, Aarhus University Hospital.
³ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Editorial

Katharine J Bar et al. Curr Opin HIV AIDS. 2021.

. 2021 Sep 1;16(5):241-242.

doi: 10.1097/COH.0000000000000698.

Katharine J Bar¹, Ole S Søgaard^{2

3}

¹ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
² Department of Infectious Diseases, Aarhus University Hospital.
³ Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

No abstract available

References

1. Hartana CA, Yu XG. Immunological effector mechanisms in HIV-1 elite controllers. Curr Opin HIV AIDS 2021; 16:243–248.
1. Jiang C, Lian X, Gao C, et al. Distinct viral reservoirs in individuals with spontaneous control of HIV-1. Nature 2020; 585:261–267.
1. Altfeld M, Kalife ET, Qi Y, et al. HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med 2006; 3:e403.
1. McMahon J, Lewin SR, Rasmussen TA. Viral, inflammatory, and reservoir characteristics of posttreatment controllers. Curr Opin HIV AIDS 2021; 16:249–256.
1. Namazi G, Fajnzylber JM, Aga E, et al. The control of HIV after antiretroviral medication pause (CHAMP) study: posttreatment controllers identified from 14 clinical studies. J Infect Dis 2018; 218:1954–1963.